These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Chromosome 3 is a valid marker for prognostic testing of biopsy material from uveal melanoma later treated by brachytherapy. Le Guin CHD; Metz KA; Lehmann N; Kreis SH; Bornfeld N; Rudolf Lohmann D; Zeschnigk M Biomarkers; 2019 Mar; 24(2):134-140. PubMed ID: 30265160 [TBL] [Abstract][Full Text] [Related]
4. Chromosome 3 analysis of uveal melanoma using fine-needle aspiration biopsy at the time of plaque radiotherapy in 140 consecutive cases: the Deborah Iverson, MD, Lectureship. Shields CL; Ganguly A; Materin MA; Teixeira L; Mashayekhi A; Swanson LA; Marr BP; Shields JA Arch Ophthalmol; 2007 Aug; 125(8):1017-24. PubMed ID: 17698747 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of chromosome 3 alterations determined by microsatellite analysis in uveal melanoma: a long-term follow-up study. Thomas S; Pütter C; Weber S; Bornfeld N; Lohmann DR; Zeschnigk M Br J Cancer; 2012 Mar; 106(6):1171-6. PubMed ID: 22353812 [TBL] [Abstract][Full Text] [Related]
6. Prognostic biopsy of choroidal melanoma: an optimised surgical and laboratory approach. Angi M; Kalirai H; Taktak A; Hussain R; Groenewald C; Damato BE; Heimann H; Coupland SE Br J Ophthalmol; 2017 Aug; 101(8):1143-1146. PubMed ID: 28596284 [TBL] [Abstract][Full Text] [Related]
7. Prognosis of uveal melanoma in 500 cases using genetic testing of fine-needle aspiration biopsy specimens. Shields CL; Ganguly A; Bianciotto CG; Turaka K; Tavallali A; Shields JA Ophthalmology; 2011 Feb; 118(2):396-401. PubMed ID: 20869116 [TBL] [Abstract][Full Text] [Related]
13. Accuracy of The Cancer Genome Atlas Classification vs American Joint Committee on Cancer Classification for Prediction of Metastasis in Patients With Uveal Melanoma. Mazloumi M; Vichitvejpaisal P; Dalvin LA; Yaghy A; Ewens KG; Ganguly A; Shields CL JAMA Ophthalmol; 2020 Mar; 138(3):260-267. PubMed ID: 31944225 [TBL] [Abstract][Full Text] [Related]
14. Monosomy 3 status of uveal melanoma metastases is associated with rapidly progressive tumors and short survival. Abdel-Rahman MH; Cebulla CM; Verma V; Christopher BN; Carson WE; Olencki T; Davidorf FH Exp Eye Res; 2012 Jul; 100():26-31. PubMed ID: 22569040 [TBL] [Abstract][Full Text] [Related]
15. Cytogenetics in the management of uveal melanoma: are we there yet? Robertson DM Arch Ophthalmol; 2008 Mar; 126(3):409-10. PubMed ID: 18332323 [No Abstract] [Full Text] [Related]
16. Chromosome 3 analysis of uveal melanoma using fine-needle aspiration biopsy at the time of plaque radiotherapy in 140 consecutive cases. Shields CL; Ganguly A; Materin MA; Teixeira L; Mashayekhi A; Swanson LA; Marr BP; Shields JA Trans Am Ophthalmol Soc; 2007; 105():43-52; discussion 52-3. PubMed ID: 18427593 [TBL] [Abstract][Full Text] [Related]
18. Association between Tumor Regression Rate and Gene Expression Profile after Iodine 125 Plaque Radiotherapy for Uveal Melanoma. Mruthyunjaya P; Seider MI; Stinnett S; Schefler A; Ophthalmology; 2017 Oct; 124(10):1532-1539. PubMed ID: 28549517 [TBL] [Abstract][Full Text] [Related]
19. Gene Expression Profiling and PRAME Status Versus Tumor-Node-Metastasis Staging for Prognostication in Uveal Melanoma. Cai L; Paez-Escamilla M; Walter SD; Tarlan B; Decatur CL; Perez BM; Harbour JW Am J Ophthalmol; 2018 Nov; 195():154-160. PubMed ID: 30092184 [TBL] [Abstract][Full Text] [Related]
20. Prognostication of uveal melanoma is simple and highly predictive using The Cancer Genome Atlas (TCGA) classification: A review. Shields CL; Dalvin LA; Vichitvejpaisal P; Mazloumi M; Ganguly A; Shields JA Indian J Ophthalmol; 2019 Dec; 67(12):1959-1963. PubMed ID: 31755428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]